Chromosomal microarray better informs brain tumor diagnosis: Robert Jenkins, M.D., Ph.D.
About this episode
(00:31)
Could you provide a little bit about yourself and your background?
(02:04)
Could you provide an overview of the chromosomal microarray assay?
(05:49)
Why should the chromosomal microarray assay be used over other available assays, such as FISH?
(08:56)
Does the chromosomal microarray provide good benefits in terms of gain of 7 and loss of 10, and EGFR amplification?
(12:03)
What's the value of utilizing the test alongside a neuro-specific NGS panel, such as Mayo Clinic Laboratories' NONCP panel?
(17:20)
How are the results used in patient care?
(19:41)
Is there anything else you feel it's important to highlight?
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Answers from the Lab
Unique Assays Advance Care of Complex Autoimmune Skin Conditions
Answers from the Lab
Digital Advances: What’s Next for Clinical Diagnostics?
Answers from the Lab
Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes
Answers from the Lab
Breakthrough Test Enhances Peripheral Neuropathy Care and Research
Answers from the Lab